ストックスクリーナーアプリを入手
8.81
4.88%
0.41
プレマーケット:
8.75
-0.06
-0.68%
Novavax Inc (NVAX) 最新ニュース
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Average PT from Analysts - MarketBeat
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025 - Insider Monkey
10 Under-the-Radar Stocks with Massive Upside for 2025 - Insider Monkey
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials - MSN
Analysts Set Novavax, Inc. (NASDAQ:NVAX) PT at $17.83 - MarketBeat
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing - Benzinga
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - The Motley Fool
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade) - Seeking Alpha
Novavax (NVAX) Rises But Trails Market: What Investors Should Know - Yahoo Finance
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax Slips 7.3% After 2024 Revenue Guidance Reaffirmed - MarketWatch
Looking Into Novavax's Recent Short Interest - Benzinga
Why Novavax (NVAX) Stock Is Falling - Benzinga
Novavax: presents its 2025 growth strategy - Marketscreener.com
Novavax Shares Strategic Updates at Healthcare Conference - TipRanks
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued - MSN
Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine - WPSD Local 6
(NVAX) On The My Stocks Page - Stock Traders Daily
Why Novavax Stock Is Volatile This Week - Benzinga
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NASDAQ:NVAX) Stock Price Down 8.2%Time to Sell? - MarketBeat
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171% - Yahoo Finance
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - MSN
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death - Yahoo Finance
Health Care Up as Vaccine Makers Surge -- Health Care Roundup - Marketscreener.com
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Yahoo! Voices
Options Alert: Why Novavax (NVAX) Could Be The Biotech Hero Of Trump 2.0 - Barchart
Novavax (NASDAQ:NVAX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Novavax Target of Unusually High Options Trading (NASDAQ:NVAX) - MarketBeat
Moderna, Novavax Stocks Climb Pre-Market On Growing Bird Flu Concerns: Retail Engagement Soars - MSN
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally - Benzinga
Novavax (NVAX) Shares Cross Above 200 DMA - Nasdaq
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns - Seeking Alpha
Why Novavax (NVAX) Stock Is Rising - Benzinga
Insiders At Novavax Sold US$713k Of Stock Potentially Indicating Weakness - Simply Wall St
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls - AOL
Insider Sell: James Young Sells 10,000 Shares of Novavax Inc (NV - GuruFocus.com
Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 4,600 Shares - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Director James F. Young Sells 5,400 Shares - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Director Rachel K. King Sells 4,150 Shares - MarketBeat
Novavax director Rachel King sells $37,435 in stock - Investing.com
Novavax director James Young sells shares worth $82,208 - Investing.com
Novavax director Rachel King sells $37,435 in stock By Investing.com - Investing.com UK
Novavax (NASDAQ:NVAX) Trading Up 6.6%Still a Buy? - MarketBeat
NVAX February 14th Options Begin Trading - Nasdaq
Novavax completes $200 million facility sale to Novo Nordisk By Investing.com - Investing.com Australia
Novavax completes $200 million facility sale to Novo Nordisk - Investing.com
Where are the Opportunities in (NVAX) - Stock Traders Daily
4.81%
大文字化:
|
ボリューム (24 時間):